BioSpace News Archive

EV Biologics Corp, OTC PINK:YECO, updated shareholders with further details about its NFT Warrant Dividend.

The Company’s common shares will continue to trade on the Toronto Stock Exchange (TSX) under the same symbol “CRDL” (its current symbol). Concurrent with the listing of Cardiol’s common shares on NASDAQ, the shares will cease to be quoted on the OTCQX.

Halberd Corporation released a 120-page compilation of medical articles in support of its Vita-Shield-MaxTM Nutraceutical product earlier.

COPENHAGEN, Denmark, August 9, 2021 – Bavarian Nordic A/S reported initial results from the first-in-human trial of ABNCoV2, led by the PREVENT-nCoV consortium.

Targovax ASA will announce its second quarter and first half 2021 results on Wednesday 18 August 2021.

Genentech, a member of the Roche Group, announced that the pivotal Phase III POLARIX trial investigating Polivy® in combination with Rituxan® plus cyclophosphamide, doxorubicin and prednisone versus Rituxan plus cyclophosphamide, doxorubicin, vincristine and prednisone met its primary endpoint by demonstrating significantly improved and clinically meaningful progression-free survival in people with previously untreated diffuse large B-cell lymphoma.

Orthokeratology is the use of contact lenses that are gas-permeable in order to reshape the cornea of the eye.

Acer Therapeutics Inc., a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, and RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, announced the submission of a New Drug Application to the U.S. FDA for ACER-001 for the treatment of Urea Cycle Disorders.

Supply of equipment and samples related to health care and medical requirements can sometimes be urgent and critical. A medical courier allows the movement from one place to another, often from the collection point of things such as blood and urine to the clinics or labs where the tests are to take place.

Over the years, biomedical researchers have increasingly focused on developing efficient and reliable methods for precise and targeted changes to virtually any point of genome of any living cell.